
Diesel fuel breached the all-time price record in Germany on Sunday at an average €2.440 ($2.820) per litre, up 1.5 cents from the previous day, according to the ADAC automobile association.
E10 petrol rose by 0.7 cents to an average €2.191 per litre.
In response to soaring oil prices resulting from the war in the Middle East, the German government passed a bill last week to restrict petrol stations to raising prices once a day, at midday, in an effort to limit price fluctuations and ensure greater transparency. The measure went into effect on Wednesday April 1.
A week ago on March 30, Germans paid an average €2.295 for a litre of diesel and €2.087 for a litre of E10 petrol.
Noon on Monday saw further increases, with the average diesel price up 6.6 cents at €2.487 and E10 also up 6.6 cents at €2.235. The ADAC sees the price increases as excessive.
Crude oil prices continued their rise. Brent crude for June delivery came in at $111 per barrel, up almost $40 since the start of the war.
latest_posts
- 1
Vote in favor of your Number one Kind of Shades - 2
Who is Artemis? Meet the Greek goddess who inspired NASA's return to the moon - 3
Figure out How to Involve a Brain science Certification in Showcasing - 4
December's overlooked meteor shower peaks next week — will the Ursids surprise us? - 5
4 Excellent Remote Headphones of 2024
Reveal Less popular Authentic Realities You Didn't Learn in School
Will Comet C/2025 R3 (PanSTARRS) be the 'great comet' of 2026?
The 10 Most Significant Virtual Entertainment Missions
How to watch Dick Clark’s New Year’s Rockin’ Eve with Ryan Seacrest: Start time, TV channel, performers and more
Figure out How to Reveal Stowed away Open Record Rewards
Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
How does spider venom damage human cells? Researchers uncover the killer mechanism of recluse spider toxin
Artemis 2 astronauts see Earth in the rear-view mirror | Space photo of the day for April 3, 2026
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug













